Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Indian Journal of Poultry Science ; 56(2):173-179, 2021.
Article in English | CAB Abstracts | ID: covidwho-1865636

ABSTRACT

Poultry enteritis is an important multifactorial disease. Avian coronavirus (ACV) is one of many viruses related to enteric diseases and infectious bronchitis. Aim of this study was to find out the occurrence of ACV in enteritis affected broiler, molecular detection, phylogenetic analysis of avian corona virus and to examine intestine and liver for gross and microscopic lesions. Dead poultry birds (N=604) affected with enteritis were examined for presence of ACV. Intestinal samples of four birds were pooled to make one biological sample enteric ACV as the causative agent of enteritis in commercial poultry sector in and around four major districts of Rajasthan by RT-PCR. Molecular characterization was carried out by partial gene sequencing. Liver and intestine were examined grossly during post-mortem and by histopathology. Out of 151 pooled samples tested 51 (35.10%) were found positive for ACV. Prevalence of enteric ACV was highest in Ajmer (45.94%) and lowest in Dungarpur (23.07%) districts. 0-1 weeks age chicken flocks were found more susceptible for enteric ACV with 33.80% prevalence. Comparison of ACV sequence of this study revealed nucleotide (nt) identities from 99.44% among themselves, 99.44% with ACV from abroad. The amino acid (aa) identities of ACV of this study among themselves and with abroad sequences was 47.06 to 100%. Further severe congestion in intestine and necrotic patches on liver were recorded. Histopathology showed severe villous atrophy, congestion and cystic glands in sub-mucosa in intestine and severe congestion and haemorrhages along with infiltration of inflammatory cells in liver parenchyma.

2.
Prostaglandins Leukot Essent Fatty Acids ; 179: 102426, 2022 04.
Article in English | MEDLINE | ID: covidwho-1763934

ABSTRACT

Many current treatment options for lung inflammation and thrombosis come with unwanted side effects. The natural omega-3 fatty acids (O3FA) are generally anti-inflammatory and antithrombotic. O3FA are always administered orally and occasionally by intravenous (IV) infusion. The main goal of this study is to determine if O3FA administered by inhalation of a nebulized formulation mitigates LPS-induced acute lung inflammation in male Wistar rats. Inflammation was triggered by intraperitoneal injection of LPS once a day for 14 days. One hour post-injection, rats received nebulized treatments consisting of egg lecithin emulsified O3, Budesonide and Montelukast, and blends of O3 and Melatonin or Montelukast or Cannabidiol; O3 was in the form of free fatty acids for all groups except one group with ethyl esters. Lung histology and cytokines were determined in n = 3 rats per group at day 8 and day 15. All groups had alveolar histiocytosis severity scores half or less than that of the disease control (Cd) treated with LPS and saline only inhalation. IL-6, TNF-α, TGF-ß, and IL-10 were attenuated in all O3FA groups. IL-1ß was attenuated in most but not all O3 groups. O3 administered as ethyl ester was overall most effective in mitigating LPS effects. No evidence of lipid pneumonia or other chronic distress was observed. These preclinical data suggest that O3FA formulations should be further investigated as treatments in lung inflammation and thrombosis related lung disorders, including asthma, chronic obstructive pulmonary disease, lung cancer and acute respiratory distress such as COVID-19.


Subject(s)
COVID-19 Drug Treatment , Fatty Acids, Omega-3 , Pneumonia , Pulmonary Disease, Chronic Obstructive , Animals , Docosahexaenoic Acids/pharmacology , Eicosapentaenoic Acid/pharmacology , Fatty Acids, Omega-3/therapeutic use , Lipopolysaccharides , Male , Pneumonia/chemically induced , Pneumonia/drug therapy , Rats , Rats, Wistar
3.
International Journal of Social Economics ; ahead-of-print(ahead-of-print):20, 2021.
Article in English | Web of Science | ID: covidwho-1612761

ABSTRACT

Purpose The objective of this paper was twofold-revisiting the in-kind public distribution system (PDS) - India's flagship food security intervention and seeking beneficiary perspectives on its efficacy. The feasibility of cash transfers as an alternative mechanism is also examined, especially in the context of the COVID-19 pandemic. Design/methodology/approach Primary and secondary data from the southern Indian state of Tamil Nadu were used. In-depth interviews with beneficiaries using phenomenology were conducted to evaluate their perception and willingness to shift to a cash-based PDS in the pre and post-pandemic periods. Secondary district-level data were also used to ascertain institutional preparedness for this shift. Findings In-depth interviews of 105 beneficiaries revealed valuable insights, which seem to have significantly changed post-pandemic. Beneficiaries in the post-pandemic period seem much more inclined toward cash transfers, though a combination of cash plus in-kind benefits seems to be strongly preferred. Secondary results pointed out to the lack of institutional preparedness in financial inclusion. The research suggested that while the existing PDS needs to be overhauled, policymakers should look at a model of cash plus in-kind transfers as a probable alternative to pure cash transfers. Originality/value There is a dearth of in-depth state-specific studies on beneficiary perception of PDS, and this is important since the economic and sociocultural milieu in each region is unique. Being the only state with universal food security, its experience could yield important insights for other states or even middle or low-income countries similar to India.

4.
Journal of Pharmaceutical Research International ; 33(47B):431-468, 2021.
Article in English | Web of Science | ID: covidwho-1551868

ABSTRACT

Introduction: COVID-19 disease is caused by SARS-CoV-2 virus and it was declared pandemic by World Health Organization (WHO) on March 11,2020. The coronavirus infection has an affinity for ACE2 receptors and by attaching to them, the virus enters the host cells. Along with many body organs like lungs, kidney, liver, upper respiratory tract, nervous system, skeletal muscles, ACE2 concentration is also found in abundance in epithelial cells of tongue and salivary glands. Materials and Methods: Recent studies, researches, documents and case reports published in the world medical literature in the year 2020-2021 were searched and documented in our study. The search engines used were PUBMED, google scholar, WEB OF SCIENCE etc. Results: Dysgeusia, xerostomia, sore throat, aphthous and herpetiform ulcers, candidiasis, enanthema, Kawasaki like lesions were the most common among various oral manifestations. Others includes plaque like changes, gingival inflammation, necrotizing gingivitis, erythema - multiforme, angina-bullosa like lesions, Melkersson-Rosenthal Syndrome, Oral mucormycosis etc.The sites of infection mainly include tongue, gingiva, hard and soft palate, buccal and labial mucosa etc. Conclusion: The etiopathogenesis of such lesions cannot be directly corelated with COVID-19 and factors such as stress, immunosuppression, co-infections, secondary lesions, opportunistic infections, systemic diseases, poor oral hygiene etc. must be considered. Management of stress is an important factor. In this review article various oral lesions are discussed in COVID-19 infection states in detail. The importance of earliest diagnosis of oral lesions is to be kept in mind to prevent further complications.

5.
biorxiv; 2021.
Preprint in English | bioRxiv | ID: ppzbmed-10.1101.2021.11.23.469790

ABSTRACT

Many current treatment options for lung inflammation and thrombosis come with unwanted side effects. The natural omega-3 fatty acids (O3FA) are generally anti-inflammatory and antithrombotic. The O3FA are always administered orally and occasionally by intravenous (IV) infusion. The main goal of this study is to determine if O3FA administered by inhalation of a nebulized formulation mitigates LPS-induced acute lung inflammation in male Wistar rats. Inflammation was triggered by intraperitoneal injection of LPS once a day for 14 days. One hour later, rats received nebulized treatments consisting of egg lecithin emulsified O3, budesonide and Montelukast, and blends of O3 and melatonin or Montelukast or Cannabidiol; O3 was in the form of free fatty acids for all groups except one group with ethyl esters. Lung histology and cytokines were determined in n=3 rats per group at day 8 and day 15. All groups had alveolar histiocytosis severity scores half or less than that of the disease control (Cd) treated with LPS and saline only inhalation. IL-6, TNF-α, TGF-β, and IL-10 were attenuated in all O3 groups. IL-1β was attenuated in most but not all O3 groups. O3 administered as ethyl ester was overall most effective in mitigating LPS effects. No evidence of lipid pneumonia or other chronic distress was observed. These preclinical data suggest that O3FA formulations should be further investigated as treatments in lung inflammation and thrombosis related lung disorders, including asthma, chronic obstructive pulmonary disease, lung cancer and acute respiratory distress like COVID-19.


Subject(s)
Lung Diseases , Respiratory Distress Syndrome , Pneumonia , Thrombosis , Lung Neoplasms , COVID-19 , Pneumonia, Lipid
6.
American Journal of Respiratory and Critical Care Medicine ; 203(9), 2021.
Article in English | EMBASE | ID: covidwho-1277437

ABSTRACT

Introduction/Rationale: The novel coronavirus disease 2019 (COVID-19) created an unprecedented healthcare crisis and has put enormous strain on hospital systems across the world. The unpredictability of this disease has led to critical care shortages such as ICU beds, ventilator availability and staffing. To our knowledge, a novel scoring criteria is not available that can assist clinicians in predicting who may decompensate and eventually require mechanical ventilation and the highest level of available care. Such a scoring criteria would be beneficial in times of surge capacity, in which the score could be applied to patients upon admission and assist in determining where resources may need to be allocated. Methods: The electronic medical records of the first 150 patients to present to a large, tertiary referral center in the Southeastern US with COVID-19 pneumonia were reviewed. A multivariable logistic regression model was used to determine odds of requiring mechanical ventilation after admission using demographic and clinical characteristics. Adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) were calculated. A prognostic index from aOR was created and validated with one-leave-out cross validation method. SAS v9.4 was used for data management and statistical data analysis. Results: Three variables were found to be directly linked with the need for mechanical ventilation in patients with COVID-19 pneumonia. An increased number of comorbidities (obesity, hypertension, diabetes mellitus, chronic lung disease or cardiovascular disease) was associated with a two-fold risk for mechanical ventilation (aOR 1.955 [95% CI=1.27-3.011]). A decreased SpO2/FiO2 ratio compared to normal range was associated with a two-fold risk in need for mechanical ventilation (aOR 1.919 [95% CI=1.226-3.002]. An increase in neutrophil/lymphocyte ratio compared to a normal range was associated with an aOR of 1.783 (95% CI=1.142-2.783). Conclusion: Our proposed scoring system is a sum score for number of comorbidities, neutrophil/lymphocyte ratio, and oxygen saturation/fraction of inspired oxygen ratio in patients with COVID-19 pneumonia. As each of these variables increase, the patients are assigned an increasing patient score based on the values found on admission. A sum score greater than eight was found to have high predictive value for requiring mechanical ventilation, including a sensitivity of 77.1%, specificity of 83.1%, positive predictive value of 71.1% and negative predictive value of 87.1%. Our score was internally validated, accurately predicting mechanical ventilation in 81% of patients, but will have to be applied to a larger sample size prospectively for external validation before clinical application is considered.

7.
Prostaglandins Leukot Essent Fatty Acids ; 162: 102183, 2020 11.
Article in English | MEDLINE | ID: covidwho-808662

ABSTRACT

COVID-19 symptoms vary from silence to rapid death, the latter mediated by both a cytokine storm and a thrombotic storm. SARS-CoV (2003) induces Cox-2, catalyzing the synthesis, from highly unsaturated fatty acids (HUFA), of eicosanoids and docosanoids that mediate both inflammation and thrombosis. HUFA balance between arachidonic acid (AA) and other HUFA is a likely determinant of net signaling to induce a healthy or runaway physiological response. AA levels are determined by a non-protein coding regulatory polymorphisms that mostly affect the expression of FADS1, located in the FADS gene cluster on chromosome 11. Major and minor haplotypes in Europeans, and a specific functional insertion-deletion (Indel), rs66698963, consistently show major differences in circulating AA (>50%) and in the balance between AA and other HUFA (47-84%) in free living humans; the indel is evolutionarily selective, probably based on diet. The pattern of fatty acid responses is fully consistent with specific genetic modulation of desaturation at the FADS1-mediated 20:3→20:4 step. Well established principles of net tissue HUFA levels indicate that the high linoleic acid and low alpha-linoleic acid in populations drive the net balance of HUFA for any individual. We predict that fast desaturators (insertion allele at rs66698963; major haplotype in Europeans) are predisposed to higher risk and pathological responses to SARS-CoV-2 could be reduced with high dose omega-3 HUFA.


Subject(s)
Coronavirus Infections/complications , Fatty Acids, Unsaturated/biosynthesis , Inflammation/etiology , Lipid Metabolism/genetics , Pneumonia, Viral/complications , Thrombosis/etiology , Betacoronavirus/physiology , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/genetics , Coronavirus Infections/metabolism , Delta-5 Fatty Acid Desaturase , Fatty Acids, Unsaturated/genetics , Genetic Predisposition to Disease , Haplotypes , Humans , Individuality , Inflammation/epidemiology , Inflammation/genetics , Inflammation/metabolism , Lipogenesis/genetics , Metabolic Networks and Pathways/genetics , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/genetics , Pneumonia, Viral/metabolism , Polymorphism, Single Nucleotide , Risk Factors , SARS-CoV-2 , Thrombosis/epidemiology , Thrombosis/genetics , Thrombosis/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL